Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,434.00
+26.50 (1.88%)
Feb 21, 2025, 3:30 PM JST
Santen Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 489,499 | 559,190 | 424,342 | 490,898 | 608,810 | 742,066 | Upgrade
|
Market Cap Growth | 8.00% | 31.78% | -13.56% | -19.37% | -17.96% | 12.77% | Upgrade
|
Enterprise Value | 410,831 | 476,424 | 362,459 | 422,435 | 555,406 | 661,036 | Upgrade
|
Last Close Price | 1434.00 | 1522.21 | 1094.42 | 1152.34 | 1398.45 | 1679.80 | Upgrade
|
PE Ratio | 18.53 | 21.00 | - | 18.04 | 89.19 | 31.42 | Upgrade
|
Forward PE | 13.70 | 17.09 | 25.03 | 16.25 | 21.32 | 20.43 | Upgrade
|
PS Ratio | 1.68 | 1.85 | 1.52 | 1.84 | 2.44 | 3.07 | Upgrade
|
PB Ratio | 1.72 | 1.83 | 1.45 | 1.46 | 1.98 | 2.45 | Upgrade
|
P/TBV Ratio | 2.70 | 2.52 | 2.15 | 2.37 | 3.13 | 4.05 | Upgrade
|
P/FCF Ratio | 10.59 | 8.83 | 21.36 | 17.11 | 17.56 | 21.75 | Upgrade
|
P/OCF Ratio | 10.00 | 7.70 | 11.42 | 10.66 | 15.69 | 18.58 | Upgrade
|
PEG Ratio | 2.27 | 2.79 | 2.79 | 2.79 | 3.56 | 3.88 | Upgrade
|
EV/Sales Ratio | 1.36 | 1.58 | 1.30 | 1.59 | 2.23 | 2.74 | Upgrade
|
EV/EBITDA Ratio | 6.35 | 6.77 | 6.90 | 7.98 | 7.90 | 11.71 | Upgrade
|
EV/EBIT Ratio | 8.82 | 9.13 | 10.27 | 11.78 | 10.38 | 16.58 | Upgrade
|
EV/FCF Ratio | 8.89 | 7.52 | 18.24 | 14.72 | 16.02 | 19.37 | Upgrade
|
Debt / Equity Ratio | - | 0.11 | 0.12 | 0.10 | 0.03 | 0.04 | Upgrade
|
Debt / EBITDA Ratio | - | 0.49 | 0.69 | 0.62 | 0.14 | 0.22 | Upgrade
|
Debt / FCF Ratio | - | 0.55 | 1.82 | 1.15 | 0.29 | 0.36 | Upgrade
|
Asset Turnover | 0.73 | 0.70 | 0.63 | 0.62 | 0.62 | 0.60 | Upgrade
|
Inventory Turnover | 2.67 | 2.99 | 2.95 | 2.79 | 2.56 | 2.69 | Upgrade
|
Quick Ratio | 1.87 | 1.99 | 1.84 | 1.91 | 2.02 | 2.64 | Upgrade
|
Current Ratio | 2.61 | 2.54 | 2.38 | 2.39 | 2.63 | 3.23 | Upgrade
|
Return on Equity (ROE) | 9.45% | 8.92% | -4.76% | 8.45% | 2.18% | 7.30% | Upgrade
|
Return on Assets (ROA) | 7.75% | 7.61% | 5.01% | 5.20% | 8.25% | 6.23% | Upgrade
|
Return on Capital (ROIC) | 11.02% | 9.74% | 6.31% | 6.53% | 10.58% | 8.15% | Upgrade
|
Return on Capital Employed (ROCE) | 16.02% | 15.22% | 10.64% | 9.85% | 16.52% | 11.68% | Upgrade
|
Earnings Yield | 5.62% | 4.76% | -3.52% | 5.54% | 1.12% | 3.18% | Upgrade
|
FCF Yield | 9.44% | 11.33% | 4.68% | 5.85% | 5.69% | 4.60% | Upgrade
|
Dividend Yield | 2.65% | 2.17% | 2.92% | 2.78% | 2.00% | 1.61% | Upgrade
|
Payout Ratio | 44.13% | 44.59% | - | 44.07% | 163.81% | 43.95% | Upgrade
|
Buyback Yield / Dilution | 4.34% | 4.98% | 3.26% | -0.02% | -0.03% | 1.75% | Upgrade
|
Total Shareholder Return | 6.99% | 7.14% | 6.18% | 2.76% | 1.97% | 3.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.